CEREP - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for CEREP Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

CEREP. The Group's principal activity is to assist the pharmaceutical and biotechnology companies in their search for effective and safe drugs. The Group provides services under Clinical Services. The Group also provides services in the field of Collaboration & Drug Discovery which range from molecular modeling and custom synthesis of libraries to lead optimization. The Group's products and services are available to the customers through flexible business models, from pure "fee for service" to integrated collaborations and partnerships. The Group also provides pharmacology and ADMET data to pharma and biotech companies worldwide. Under Clinical Services, the Group offers clinical trials management and monitoring, data management, biostatistical analysis, clinical pharmacology and other drug development consulting services. The Group operates in Europe, North America and Asia.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report